The Bubble Bursts: Germany’s OTC Market Slumps As COVID-19 Impact Deepens
After an almost 50% rise in sales in March, Germany's OTC market suffered a severe contraction in April as the 'boom' effect of the coronavirus wore off, according to data from Sempora Consulting.
You may also be interested in...
What should consumer health companies be doing as Europe comes out of lockdown? Invest in key brands, says Sempora Consulting's managing partner Tobias Brodtkorb, and consider seizing the opportunity presented by the long-term trend for natural OTCs, which has been accelerated by the coronavirus pandemic.
Germany's OTC market blues continue as the coronavirus lockdown bites into May.
A weak cold season last year and a booming online pharmacy market in Germany contributed to a significant decline in the number of "grünes Rezept" recommendation prescriptions issued in the country in 2019, according to new data from IQVIA.